Evidence map›Paper›PMID 29402848›Full record

Trial reportMedical principles and practice : international journal of the Kuwait University, Health Science Centre2018

Do Statins Affect Thyroid Volume and Nodule Size in Patients with Hyperlipidemia in a Region with Mild-to-Moderate Iodine Deficiency? A Prospective Study.

Canan Demir, Cuneyd Anil, Yusuf Bozkus, Umut Mousa, Altug Kut, Asli Nar, Neslihan B Tutuncu

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Canan DemirDepartment of Endocrinology and Metabolism, Baskent University School of Medicine, Ankara, Turkey.
Cuneyd AnilDepartment of Endocrinology and Metabolism, Baskent University School of Medicine, Ankara, Turkey.
Yusuf BozkusDepartment of Endocrinology and Metabolism, Baskent University School of Medicine, Ankara, Turkey.
Umut MousaDepartment of Endocrinology and Metabolism, Baskent University School of Medicine, Ankara, Turkey.
Altug KutDepartment Family Medicine, Baskent University School of Medicine, Ankara, Turkey.
Asli NarDepartment of Endocrinology and Metabolism, Baskent University School of Medicine, Ankara, Turkey.
Neslihan B TutuncuDepartment of Endocrinology and Metabolism, Baskent University School of Medicine, Ankara, Turkey.
Başkent University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study was to assess the antiproliferative pleiotropic effects of statins on thyroid function, volume, and nodularity. SUBJECTS AND

methodsOne hundred and six hyperlipidemic patients were included in this prospective study. The 69 patients in the statin groups received atorvastatin (16 received 10 mg and 18 received 20 mg) or rosuvastatin (20 received 10 mg and 15 received 20 mg). The 37 patients in the control group, assessed as not requiring drugs, made only lifestyle changes. Upon admission and after 6 months, all patients were evaluated by ultrasonography as well as for lipid variables (total cholesterol, high- and low-density lipoprotein cholesterol, and triglycerides) and thyroid function and structure.

resultsAfter 6 months, no differences in thyroid function, thyroid volume, the number of thyroid nodules, or nodule size were observed in the statin and control groups. In a subgroup analysis, total thyroid volume had decreased more in patients receiving 20 mg of rosuvastatin than that in the control group (p < 0.05). Maximum nodule size had decreased more in those receiving 10 mg of rosuvastatin (p < 0.05).

conclusionsOur results suggest an association between rosuvastatin treatment and smaller thyroid volume and maximum nodule diameter; this could be attributable to the antiproliferative effects of statin therapy on the thyroid.

Indexed as

AdultAgedAged, 80 and overAtorvastatinCoronary DiseaseDiabetes Mellitus, Type 2Dose-Response Relationship, DrugFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaHypertensionLife StyleLipidsMaleMiddle AgedAtorvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsRosuvastatin CalciumAtorvastatinHMG-CoA reductase inhibitorHyperlipidemiaRosuvastatinStatinsThyroid noduleThyroid volume

Identifiers

PMID29402848
PMCPMC5968300
OpenAlexW2794071709

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.